New York S06509 authorizes the creation of a state debt of up to $1 billion to fund Alzheimer's disease research.

New York S06509, known as the Alzheimer's research bond act of 2025, authorizes the creation of a state debt up to $1 billion to fund research into Alzheimer's disease. The proceeds from the bond sales will be used for research grants and collaborations related to the causes, treatment, and clinical trials of medications for Alzheimer's. The act requires the proposal to be submitted to the people in a general election in November 2025, where it must receive a majority vote to take effect. The bonds will be issued as tax-exempt under federal law.

New York S06509 authorizes the creation of a state debt of up to $1 billion to fund Alzheimer's disease research.

New York S06509, known as the Alzheimer's research bond act of 2025, authorizes the creation of a state debt up to $1 billion to fund research into Alzheimer's disease. The proceeds from the bond sales will be used for research grants and collaborations related to the causes, treatment, and clinical trials of medications for Alzheimer's. The act requires the proposal to be submitted to the people in a general election in November 2025, where it must receive a majority vote to take effect. The bonds will be issued as tax-exempt under federal law.